Form EFFECT Can-Fite BioPharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2025 |
| Accession Number: | 0001213900-25-085639 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can-Fite Secures Japanese Patent Allowance for Namodenoson's Anti-Obesity Technology
- World’s First AGI ‘Smart City’ Clinical Trial Opens Waiting List This Monday (Veterans First for America)
- Dogecoin Price Prediction 2026: Can DOGE Run, and Why Early Buyers Are Joining the Bullski Priority List
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
